ArticleAdvanced functional materials2025
Synthetic Strategy for mRNA Encapsulation and Gene Delivery with Nanoscale Metal-Organic Frameworks.
Article in Advanced functional materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Review
- A worm-like nucleic acid nanostructure for gene delivery and endosomal escape via ClC3 ion exchanger.Science advances · 2026Article
- Transfection Technologies for Next-Generation Therapies.Journal of clinical medicine · 2025Review
- Metal-Organic Frameworks as Advanced Gene Delivery Vectors: Mechanisms, Functionalization, and Biomedical Applications.International journal of nanomedicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Metal-organic frameworks (MOFs) have evolved from uses in catalysis and gas storage to exciting applications in biomedicine, particularly in drug delivery. Initially, MOFs are primarily used to deliver small molecules, recent innovations have shifted focus toward more complex nucleic acids like DNA, short guide RNA (sgRNA), and short interfering RNA (siRNA). Remarkably, no studies to date have demonstrated the encapsulation and delivery of messenger RNA (mRNA) via MOFs in vitro and in vivo. This study addresses that gap by identifying synthetic conditions to encapsulate and deliver mRNA using zeolitic imidazole framework-8 (ZIF-8). Early attempts show mRNA loading in ZIF-8 but loss of mRNA in biological media. To overcome this challenge, polyethyleneimine (PEI) is incorporated into the formulation, forming a robust polymer complex core-MOF shell particle. This system stabilizes mRNA complexes and delays their release, resulting in effective protein expression in multiple cell lines and mice, performing on par with commercial lipid-based systems. Here, the first investigation into thermally stable mRNA storage using ZIF-8 demonstrates successful protein expression after three months of room-temperature storage in vitro and one month in vivo. These findings broaden the scope of MOF-based therapeutic delivery and open new avenues for long-term mRNA storage and transport.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.